TITLE:
      Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
SUMMARY:
      The purpose of this study is to evaluate safety issues pertaining to dihydrexidine (DHX), to
      cocaine, and to its interaction, and to determine how pretreatment with DHX modifies the
      subjective as well as physiological effects of cocaine infusion.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F, ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
